Afleveringen
-
Join Drs Forest Arnold and Brittanie West as they discuss their personal experience preventing and managing RSV in adults in their Appalachian communities.
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/998284. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview
RSV in Rural Communities: Lessons From Appalachia https://www.medscape.com/viewarticle/985982
CDC RSV Surveillance and Research https://www.cdc.gov/rsv/research/index.html
American Hospital Association Rural Report rural-report-2019.pdf (aha.org) https://www.aha.org/system/files/2019-02/rural-report-2019.pdf
Physician Learning Preferences physician-learning-report-2022.pdf (doximity.com) https://press.doximity.com/reports/physician-learning-report-2022.pdf
Do You Spend More Time Searching for Medical Information Than the Average American? https://swnsdigital.com/us/2020/11/do-you-spend-more-time-searching-for-medical-information-than-the-average-american/
One Assay to Test Them All: Multiplex Assays for Expansion of Respiratory Virus Surveillance https://pubmed.ncbi.nlm.nih.gov/37168265/
Respiratory Syncytial Virus Hospitalization Surveillance Network (RSV-NET) https://www.cdc.gov/rsv/research/rsv-net/index.html
RSVVaxView https://www.cdc.gov/vaccines/imz-managers/coverage/rsvvaxview/index.html
REVIRAL 1 https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/reviral-1/
A Randomized, Placebo-Controlled, Respiratory Syncytial Virus Human Challenge Study of the Antiviral Efficacy, Safety, and Pharmacokinetics of RV521, an Inhibitor of the RSV-F Protein https://pubmed.ncbi.nlm.nih.gov/31712214/
-
Join Drs Forest Arnold and Angela R. Branche as they discuss the epidemiology of RSV, the importance of an accurate diagnosis, treatment options, cohorting, and risk factors.
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/998283. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview
Seasonality of Respiratory Syncytial Virus — United States, 2017–2023 https://www.cdc.gov/mmwr/volumes/72/wr/mm7214a1.htm
Rates of Medically Attended RSV Among US Adults: A Systematic Review and Meta-analysis https://pubmed.ncbi.nlm.nih.gov/35873302/
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test https://pubmed.ncbi.nlm.nih.gov/33298613/
Comparative Analysis of Three Multiplex Platforms for the Detection of Respiratory Viral Pathogens https://pubmed.ncbi.nlm.nih.gov/36099751/
Centers for Disease Control and Prevention: Respiratory Syncytial Virus (RSV) https://www.cdc.gov/rsv/index.html
-
Zijn er afleveringen die ontbreken?
-
Join Drs Forest Arnold and Hannah Nam as they discuss preventing RSV outbreaks within healthcare facilities, and strategies to minimize RSV transmission among healthcare workers and patients.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/998282). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview
Respiratory Syncytial Virus Hospitalization Surveillance Network (RSV-NET) https://www.cdc.gov/rsv/research/rsv-net/index.html
CDC – Respiratory Syncytial Virus (RSV) Vaccination Coverage and Intent for Vaccination, Adults 60 Years and Older, United States https://www.cdc.gov/vaccines/imz-managers/coverage/rsvvaxview/adults-60-coverage-intent.html
CDC - Healthcare Providers: RSV Vaccination for Adults 60 Years of Age and Over https://www.cdc.gov/vaccines/vpd/rsv/hcp/older-adults.html
Respiratory Syncytial Virus (RSV) Vaccine, Adjuvanted (Rx) – Arexvy https://reference.medscape.com/drug/arexvy-respiratory-syncytial-virus-rsv-vaccine-adjuvanted-4000359
Respiratory Syncytial Virus (RSV) Vaccine (Rx) – Abrysvo https://reference.medscape.com/drug/abrysvo-respiratory-syncytial-virus-rsv-vaccine-4000347
-
Join Drs Forest Arnold and Christopher Robinson as they discuss long-term outcomes of severe RSV infection in adults.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/998281). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview
Neurologic Manifestations of Severe Respiratory Viral Contagions https://pubmed.ncbi.nlm.nih.gov/32426749/
Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) https://emedicine.medscape.com/article/235980-overview
Excitotoxicity: Still Hammering the Ischemic Brain in 2020 https://pubmed.ncbi.nlm.nih.gov/33192266/
Clinical Manifestations and Pathogenesis of Acute Necrotizing Encephalopathy: The Interface Between Systemic Infection and Neurologic Injury https://pubmed.ncbi.nlm.nih.gov/35058867/
Acute Disseminated Encephalomyelitis https://www.ncbi.nlm.nih.gov/books/NBK430934/
Mild Encephalopathy With Reversible Splenial Lesion: Description of Nine Cases and Review of the Literature https://pubmed.ncbi.nlm.nih.gov/33839562/
Respiratory Syncytial Virus Infects Peripheral and Spinal Nerves and Induces Chemokine-Mediated Neuropathy https://pubmed.ncbi.nlm.nih.gov/38135285/
Selective Serotonin Reuptake Inhibitors https://www.ncbi.nlm.nih.gov/books/NBK554406/
-
Join Drs Forest Arnold and Lin Chen as they discuss RSV and traveler health.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/998279). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009-2019: A Study of the National (Nationwide) Inpatient Sample https://pubmed.ncbi.nlm.nih.gov/35968878/
Mortality Associated With Influenza and Respiratory Syncytial Virus in the US, 1999-2018 https://pubmed.ncbi.nlm.nih.gov/35226079/
Estimated Incidence of Respiratory Hospitalizations Attributable to RSV Infections Across Age and Socioeconomic Groups https://pubmed.ncbi.nlm.nih.gov/36280891/
The Annual Economic Burden of Respiratory Syncytial Virus in Adults in the United States https://pubmed.ncbi.nlm.nih.gov/38060972/
Almost 200 People Reported COVID-19 After Attending CDC Conference https://www.idse.net/Covid-19/Article/05-23/COVID-COVID-19-CDC-Conference-Outbreak/70425
CDC Traveler's Health Branch https://www.cdc.gov/ncezid/dgmq/focus-areas/travelers-health.html
Traveler-Based Genomic Surveillance for Early Detection of New SARS-CoV-2 Variants https://wwwnc.cdc.gov/travel/page/travel-genomic-surveillance
CDC Expands Testing of International Air Traveler Samples to Include Flu, RSV, and Other Respiratory Viruses https://www.cdc.gov/media/releases/2023/s1107-testing-respiratory-viruses.html
GeoSentinel https://geosentinel.org/
Travellers and Influenza: Risks and Prevention https://pubmed.ncbi.nlm.nih.gov/28077609/
-
Join Drs Forest Arnold and Edward Walsh as they discuss risk factors and complications of RSV in adults.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/998278). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
RSV Surveillance & Research https://www.cdc.gov/rsv/research/index.html
Respiratory Viral Infections in the Elderly https://pubmed.ncbi.nlm.nih.gov/33749408/
Structure and Function of Respiratory Syncytial Virus Surface Glycoproteins https://pubmed.ncbi.nlm.nih.gov/24362685/
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus https://pubmed.ncbi.nlm.nih.gov/24179220/
Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines https://pubmed.ncbi.nlm.nih.gov/37887775/
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults https://pubmed.ncbi.nlm.nih.gov/37018468/
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults https://pubmed.ncbi.nlm.nih.gov/38091530/
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults https://pubmed.ncbi.nlm.nih.gov/36791160/
Vaccine Adverse Event Reporting System https://vaers.hhs.gov/reportevent.html
RSV ACIP Vaccine Recommendations https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/rsv.html
-
Rates of RSV are rising in rural communities. How are rural healthcare providers responding? Join Drs Forest Arnold and Brittanie West as they discuss.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/985982). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview
Hemoglobin A1c Testing https://emedicine.medscape.com/article/2049478-overview
The Utility of Point of Care Ultrasonography (POCUS) https://pubmed.ncbi.nlm.nih.gov/34840746/
Bedside Lung Ultrasound in Emergency Protocol as a Diagnostic Tool in Patients of Acute Respiratory Distress Presenting to Emergency Department https://pubmed.ncbi.nlm.nih.gov/29937643/
Noncardiogenic Pulmonary Edema Imaging https://emedicine.medscape.com/article/360932-overview
Procalcitonin (PCT) https://emedicine.medscape.com/article/2096589-overview
RSV-associated Hospitalization Surveillance Network https://www.cdc.gov/rsv/research/rsv-net/dashboard.html
Evaluation of the Alinity m Resp-4-Plex Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2, Influenza A Virus, Influenza B Virus, and Respiratory Syncytial Virus https://pubmed.ncbi.nlm.nih.gov/35107357/
State-level Estimates of COPD https://www.cdc.gov/copd/data-and-statistics/state-estimates.html
ACIP Recommendations https://www.cdc.gov/vaccines/acip/recommendations.html
CDC Recommends a Powerful New Tool to Protect Infants From the Leading Cause of Hospitalization https://www.cdc.gov/media/releases/2023/p-0803-new-tool-prevent-infant-hospitalization-.html
Evidence to Recommendations for Nirsevimab https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2023-02/slides-02-23/rsv-pediatric-04-jones-508.pdf
-
Dr Barney Graham, Time's 2021 Hero of the Year for his work on the COVID-19 vaccine, joins Dr Forest Arnold in this episode covering the groundbreaking work done to develop an RSV vaccine.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/985981). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview
Field Evaluation of a Respiratory Syncytial Virus Vaccine and a Trivalent Parainfluenza Virus Vaccine in a Pediatric Population https://pubmed.ncbi.nlm.nih.gov/4305200/
Structure and Function of Respiratory Syncytial Virus Surface Glycoproteins https://pubmed.ncbi.nlm.nih.gov/24362685/
Identification and Characteristics of Fusion Peptides Derived From Enveloped Viruses https://pubmed.ncbi.nlm.nih.gov/34497798/
Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease https://pubmed.ncbi.nlm.nih.gov/26677198/
Structure-based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus https://pubmed.ncbi.nlm.nih.gov/24179220/
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine https://www.fda.gov/news-events/press-announcements/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine
Vaccine-associated Enhanced Disease: Case Definition and Guidelines for Data Collection, Analysis, and Presentation of Immunization Safety Data https://pubmed.ncbi.nlm.nih.gov/33637387/
Th1 and Th2 Responses: What Are They? https://pubmed.ncbi.nlm.nih.gov/10938051/
Cytokine Pathways in Allergic Disease https://pubmed.ncbi.nlm.nih.gov/22301949/
-
Treatment therapies for adults with RSV have been elusive, but there are promising breakthroughs on the horizon. Join Drs Forest Arnold and Richard Plemper as they discuss.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/985980). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Cell Entry of Enveloped Viruses https://pubmed.ncbi.nlm.nih.gov/21927634/
Product Review on the Monoclonal Antibody Palivizumab for Prevention of Respiratory Syncytial Virus Infection https://pubmed.ncbi.nlm.nih.gov/28605249/
Palivizumab for Preventing Severe Respiratory Syncytial Virus (RSV) Infection in Children https://pubmed.ncbi.nlm.nih.gov/34783356/
Nirsevimab: A Promising Therapy for RSV https://pubmed.ncbi.nlm.nih.gov/35544094/
Nirsevimab for Prevention of RSV in Healthy Late-preterm and Term Infants https://pubmed.ncbi.nlm.nih.gov/35235726/
Oral GS-5806 Activity in a Respiratory Syncytial Virus Challenge Study https://pubmed.ncbi.nlm.nih.gov/25140957/
A Phase 2b, Randomized, Double-blind, Placebo-controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Lower Respiratory Tract https://pubmed.ncbi.nlm.nih.gov/31915807/
Ark Biopharmaceutical Presents Positive Results in Phase 3 AIRFLO Study of Ziresovir in RSV-infected Hospitalized Infants at 12th International RSV Symposium https://www.globenewswire.com/en/news-release/2022/10/07/2530040/0/en/Ark-Biopharmaceutical-Presents-Positive-Results-in-Phase-3-AIRFLO-Study-of-Ziresovir-in-RSV-Infected-Hospitalized-Infants-at-12th-International-RSV-Symposium.html
Structural Insight Into Paramyxovirus and Pneumovirus Entry Inhibition https://pubmed.ncbi.nlm.nih.gov/32245118/
Molnupiravir for Treatment of COVID-19 https://pubmed.ncbi.nlm.nih.gov/35134041/
NIH COVID-19 Treatment Guidelines—Molnupiravir https://www.covid19treatmentguidelines.nih.gov/therapies/antivirals-including-antibody-products/molnupiravir/
Quantitative Efficacy Paradigms of the Influenza Clinical Drug Candidate EIDD-2801 in the Ferret Model https://pubmed.ncbi.nlm.nih.gov/31945316/
Compound Summary Molnupiravir https://pubchem.ncbi.nlm.nih.gov/compound/Molnupiravir
-
RSV infection before or after bone marrow transplantation or CAR T-cell therapy can be challenging to manage. Tune in to hear experts Drs Forest Arnold and Melody Smith discuss.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/985979). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview
Hematopoietic Stem Cell Transplantation (HSCT) https://emedicine.medscape.com/article/208954-overview
Cancer Immunotherapy With Chimeric Antigen Receptor (CAR) T Cells https://emedicine.medscape.com/article/2500108-overview
Respiratory Syncytial Virus Hospitalization Surveillance Network (RSV-NET) https://www.cdc.gov/rsv/research/rsv-net/index.html
Diagnosis of Respiratory Syncytial Virus Infection: Comparison of Reverse Transcription-PCR to Viral Culture and Serology in Adults With Respiratory Illness https://pubmed.ncbi.nlm.nih.gov/11880399/
Conditioning Regimen https://www.cancer.gov/publications/dictionaries/cancer-terms/def/conditioning-regimen
Ribavirin (Rx) https://reference.medscape.com/drug/rebetol-ribasphere-ribavirin-342625
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine https://www.fda.gov/news-events/press-announcements/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine
Graft Versus Host Disease (GVHD) https://emedicine.medscape.com/article/429037-overview
Infections After Hematopoietic Stem Cell Transplantation https://emedicine.medscape.com/article/1013470-overview#a5
-
Join Drs Forest Arnold and Laura Morton as they discuss the diagnosis and treatment of RSV in older adults living in long-term care facilities and congregational living spaces.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/985978). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview
Ribavirin (Rx) https://reference.medscape.com/drug/rebetol-ribasphere-ribavirin-342625
The Immune System in the Elderly: A Fair Fight Against Diseases? https://www.medscape.com/viewarticle/780507_2
Gov. Beshear: Long-Term Care Task Force Working to Protect Kentuckians https://www.kentucky.gov/Pages/Activity-stream.aspx?n=GovernorBeshear&prId=133
RSV in Older Adults and Adults With Chronic Medical Conditions https://www.cdc.gov/rsv/high-risk/older-adults.html
The Flutter https://www.physio-pedia.com/Flutter
Incentive Spirometry https://www.physio-pedia.com/Incentive_Spirometry
Advance Care Planning: Advance Directives for Healthcare https://www.nia.nih.gov/health/advance-care-planning-advance-directives-health-care
-
Join Drs Forest Arnold and Victoria Statler as they discuss RSV after the COVID-19 pandemic. Tune in to hear about an increase in hospitalization rates, surprising seasonal shifts, and more.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/985977). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
CDC RSV National Trends https://www.cdc.gov/surveillance/nrevss/rsv/natl-trend.html
RSV-NET https://www.cdc.gov/rsv/research/rsv-net/overview-methods.html
Palivizumab for the Prevention of Respiratory Syncytial Virus Infection https://pubmed.ncbi.nlm.nih.gov/20705882/
Structure and Function of Respiratory Syncytial Virus Surface Glycoproteins https://pubmed.ncbi.nlm.nih.gov/24362685/
Updated Guidance: Use of Palivizumab Prophylaxis to Prevent Hospitalization From Severe Respiratory Syncytial Virus Infection During the 2022-2023 RSV Season https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/interim-guidance-for-use-of-palivizumab-prophylaxis-to-prevent-hospitalization/
Type and Duration of Precautions Recommended for Selected Infections and Conditions https://www.cdc.gov/infectioncontrol/guidelines/isolation/appendix/type-duration-precautions.html
